9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
Clinical trial NCT06896188 · RECRUITING
Trial details
- NCT number
- NCT06896188
- Sponsor
- Anwaar Saeed
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2027-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.